✦ LIBER ✦

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder*

✍ Scribed by Liebowitz, Michael R.; Manley, Amy L.; Padmanabhan, Sudharshan K.; Ganguly, Rita; Tummala, Raj; Tourian, Karen A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind, randomized, placebo-cont

✍ Michael R Liebowitz, Karen A Tourian, Eunhee Hwang, Linda Mele 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 214 KB

An Evaluation of Sexual Functioning in E

✍ Anita H. Clayton; Sujana Reddy; Kristen Focht; Jeff Musgnung; Rana Fayyad 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 439 KB

Safety and Tolerability of Desvenlafaxin

✍ Findling, Robert L.; Groark, James; Chiles, Deborah; Ramaker, Sara; Yang, Lingfe 📂 Article 📅 2014 🏛 Mary Ann Liebert 🌐 English ⚖ 403 KB

Remission Rates with Milnacipran 100 Mg/

✍ Dr Kazuo Okumura, Toshiaki A. Furukawa 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 107 KB

576 - The efficacy and safety of ziprasi

✍ David Daniel; Karen Reeves; Edmund P Harrigan 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Desvenlafaxine 50 mg/d improves fun

✍ C.J. Guico-Pabia; Q. Jiang; P. Ninan⁎; B. Pitrosky; K.A. Tourian 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB